Llwytho...
Advancing clinical development pathways for new CFTR modulators in cystic fibrosis
Cystic fibrosis (CF) is a life-shortening genetic disease affecting approximately 70 000 individuals worldwide. Until recently, drug development efforts have emphasised therapies treating downstream signs and symptoms resulting from the underlying CF biological defect: reduced function of the CF tra...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Thorax |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BMJ Publishing Group
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4853537/ https://ncbi.nlm.nih.gov/pubmed/26903594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thoraxjnl-2015-208123 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|